Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
pfizer
san diego blog main
san diego top stories
akcea therapeutics
american cancer society
amgen
anylam pharmaceuticals
avelumab
big pharma
biotech
biovex
boehringer ingelheim
boston blog main
boston top stories
breast cancer
cancer
cardiomyopathy
checkpoint inhibitor
chemotherapy
city hill ventures
clinical trials
delos capital
drugs
erasca
imlygic
immunotherapy
inotersen
jonathan lim
matt coffey
merck kgaa
national cancer institute
national top stories
neuropathy
new york
new york blog main
new york top stories
oncolytic virus
oncolytics biotech
What
approved
2
×
pfizer
2
×
ago
akcea
alnylam
amyloidosis
attr
available
battle
bio
cancer
combo
companies
dating
debilitating
disease
drug
fda
game
genetic
happening
immunotherapies
kgaa
medications
medicines
merck
oks
oncolytics
patients
pharmaceutical
rare
sets
sorts
speed
study
tacks
testing
there’s
transthyretin
year
Language
Current search:
pfizer
×
approved
×
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
